Ignite Creation Date:
2024-05-06 @ 12:13 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03708432
Status:
COMPLETED
Last Update Posted:
2024-02-26
First Post:
2018-10-13
Brief Title:
500mg Fulvestrant in HR MBC
Sponsor:
Fudan University
Organization:
Fudan University
Study Overview
Official Title:
An Observational Retrospective Study of 500mg Fulvestrant in Hormone ReceptorHER2- Advanced Breast Cancer
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the real world use of 500mg Fulvestrant in HR MBC
Detailed Description:
An observational retrospective study of 500mg Fulvestrant in hormone receptorHER2- advanced breast cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None